Chemisty and Biological Activity
Chemical Formula
C41H64O14
Chemical Name
4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5- [(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl- oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13- dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one
Chemical Structure
Molecular Weight
780.938 g/mol
Physical State
Solid
Melting Point
248-250 oC
Water Solubility
Insoluble
Isoelectric Point
Not Available
Organisms Affected
Humans and other mammals
Phase 1 Metabolising Enzyme (1-st Step of Metabolism)
Not Available
Primary Drug Target
| Name | Sodium/potassium-transporting ATPase alpha-1 chain | | Gene Name | ATP1A1 | | Synonyms | Sodium/potassium-transporting ATPase alpha-1 chain precursor; EC 3.6.3.9; Sodium pump 1; Na+/K+ ATPase 1 | | General Function | Inorganic ion transport and metabolism | | Specific Function | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. | | Reaction | ATP + H2O + Na+(in) + K+(out) = ADP + phosphate + Na+(out) + K+(in) |
|
